The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

Home / Healthcare and public health research / The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

March 10, 2021 Dario Scaramuzzi 0 Comments 10 tags

As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO), the WHO Regional Office for Africa (AFRO), and the WHO Country Office (PO) in the Republic of Congo provided technical assistance to support the Directorate of Pharmacy and Medicine (DPM) of Congo from February 15 to 19 2021 in Brazzaville (Republic of Congo).

The Global Benchmarking Tool (GBT) integrates the Maturity Level (ML) of the various drug regulatory functions in a computerized platform that facilitates its use and the ranking of maturity indicators. This self-assessment has enabled several countries in the sub-region to identify their ML as well as to put in place institutional development plans (IDPs) in order to access a ML which guarantees safety, quality and effectiveness of drugs in development and in circulation.

Click here to for news release in English.

Explore More

INTEGRATION

“This project will improve malaria prevention strategies for both children, pregnant women and families as a whole as the study is being conducted in families which will raise awareness of

With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union

The spread of Mpox virus (MPXV) in Sub-Saharan Africa, specifically Democratic Republic of Congo (DRC) and Republic of Congo (RoC) presents an urgent public health concern with global implications. MPXV cases

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT)

Leave a Reply Cancel reply

Explore More

INTEGRATION

Liberia

A multidisciplinary consortium of African and European researchers responded to the urgent call from the European Union by developing a research project on the current Monkeypox outbreak in central Africa.